Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Cerilliant
Moodys
Fish and Richardson
US Army
McKesson
Baxter
Medtronic

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,128,143

« Back to Dashboard

Summary for Patent: 5,128,143
Title: Sustained release excipient and tablet formulation
Abstract:A slow release pharmaceutical excipient of an inert diluent and a hydrodrophilic material including xanthan gum and a galactomannan gum capable of cross-linking the xanthan gum in the presence of aqueous solutions.
Inventor(s): Baichwal; Anand R. (Poughkeepsie, NY), Staniforth; John N. (Bath, GB2)
Assignee: Edward Mendell Co., Inc. (Patterson, NY)
Application Number:07/491,189
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,128,143
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation;

Drugs Protected by US Patent 5,128,143

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,128,143

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 147974 ➤ Try a Free Trial
Austria 91887 ➤ Try a Free Trial
Australia 2403392 ➤ Try a Free Trial
Australia 4305789 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Mallinckrodt
Queensland Health
Deloitte
Citi
US Army
Moodys
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.